EA200601566A1 - Кристаллические формы фармацевтического соединения - Google Patents

Кристаллические формы фармацевтического соединения

Info

Publication number
EA200601566A1
EA200601566A1 EA200601566A EA200601566A EA200601566A1 EA 200601566 A1 EA200601566 A1 EA 200601566A1 EA 200601566 A EA200601566 A EA 200601566A EA 200601566 A EA200601566 A EA 200601566A EA 200601566 A1 EA200601566 A1 EA 200601566A1
Authority
EA
Eurasian Patent Office
Prior art keywords
crystal forms
pharmaceutical compounds
methyl
benzodiazocine
diindolo
Prior art date
Application number
EA200601566A
Other languages
English (en)
Russian (ru)
Inventor
Майкл Харолд Рок
Хейди Лопес Де Диего
Ким Лассе Кристенсен
Оле Нильсен
Андерс Буур
Марк Хауэллз
Original Assignee
Х. Лундбекк А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Х. Лундбекк А/С filed Critical Х. Лундбекк А/С
Priority claimed from PCT/DK2005/000127 external-priority patent/WO2005082920A1/en
Publication of EA200601566A1 publication Critical patent/EA200601566A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EA200601566A 2004-02-27 2005-02-24 Кристаллические формы фармацевтического соединения EA200601566A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200400326 2004-02-27
PCT/DK2005/000127 WO2005082920A1 (en) 2004-02-27 2005-02-24 Crystalline forms of a pharmaceutical compound

Publications (1)

Publication Number Publication Date
EA200601566A1 true EA200601566A1 (ru) 2006-12-29

Family

ID=36607170

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200601566A EA200601566A1 (ru) 2004-02-27 2005-02-24 Кристаллические формы фармацевтического соединения

Country Status (10)

Country Link
KR (1) KR20070012644A (ko)
CN (1) CN100591685C (ko)
AR (1) AR047821A1 (ko)
CA (1) CA2762878C (ko)
EA (1) EA200601566A1 (ko)
ES (1) ES2397342T3 (ko)
HK (1) HK1102087A1 (ko)
TW (1) TW200530254A (ko)
UA (1) UA90259C2 (ko)
ZA (1) ZA200606556B (ko)

Also Published As

Publication number Publication date
CN100591685C (zh) 2010-02-24
HK1102087A1 (en) 2007-11-02
CA2762878A1 (en) 2005-09-09
ZA200606556B (en) 2008-02-27
CA2762878C (en) 2014-08-19
UA90259C2 (en) 2010-04-26
AR047821A1 (es) 2006-02-22
TW200530254A (en) 2005-09-16
KR20070012644A (ko) 2007-01-26
CN1922196A (zh) 2007-02-28
ES2397342T3 (es) 2013-03-06

Similar Documents

Publication Publication Date Title
WO2007083188A3 (en) Improved process for the preparation of an optically active 5h-pyrrolo [3,4-b] pyrazine derivative
WO2006069155A3 (en) Inhibitors of protein arginine methyl transferases
EE05222B1 (et) Triasolo(4,5-d)primidiinihendi kristalne ja amorfne vorm, meetod selle valmistamiseks ning kasutamine
EP1648853A4 (en) PHENETHYLARYLATER-BASED COMPOSITIONS AS A MEANS FOR THE SOLUBILIZATION OF ORGANIC ACTIVE SUBSTANCES
SG153039A1 (en) Crystalline polymorphic forms of monosodium n-[8- (2hydroxybenzoyl)amino]caprylate
ZA200606220B (en) Galenic formulations of organic compounds
EA200800992A1 (ru) 2-амино-7,8-дигидро-6н-пиридо[4,3-d]пиримидин-5-оны, способ их получения, способ терапии с их помощью, компонент композиции и композиция на их основе, 2,4-диоксопиперидиновые соединения для их получения
EP1804794A4 (en) SPIROPIPERIDINE COMPOUNDS AS BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
EP1799208A4 (en) AROMATIC HETEROCYCLIC COMPOUNDS AS SECRETAGOGUES OF GROWTH HORMONE
IL163667A0 (en) Novel sustained release pharmaceutical compounds to preventabuse of controlled substances
AU2006224295A8 (en) N- (N-sulfonylaminomethyl) cyclopropanecarboxamide derivatives useful for the treatment of pain
EA200801663A1 (ru) КРИСТАЛЛИЧЕСКАЯ ФОРМА 1'-(1-МЕТИЛЭТИЛ)-4'-[(2-ФТОР-4-МЕТОКСИФЕНИЛ)МЕТИЛ]-5'-МЕТИЛ-1H-ПИРАЗОЛ-3'-O-β-D-ГЛЮКОПИРАНОЗИДА, СПОСОБ ЕГО ПОЛУЧЕНИЯ И ЕГО ПРИМЕНЕНИЕ ДЛЯ ПРИГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ
NZ600161A (en) Novel tricyclic compounds
IL183587A0 (en) Methods of using [3.2.0] heterocyclic compounds and analogs thereof
ZA200608361B (en) Crystalline polymorph of bazedoxifene acetate
DK1924585T3 (da) Hidtil ukendt krystallinsk for af et pyridazino[4,5-b]indol-derivat
WO2005062897A3 (en) Polymorphs of ezetimibe and processes for the preparation thereof
SI1685125T1 (sl) Derivati pirola, primerni za zdravljenje proliferativnih bolezni
AU2003239508A8 (en) Indole compounds useful as impdh inhibitors
TW200942546A (en) A crystalline form of (R)-6-cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one
EA200970432A1 (ru) 8-сульфонил-1,3,4,8-тетрагидро-2н-[1,4]оксазепино[6,7-e] индольные производные и их использование в качестве 5-нт6 рецепторных лигандов
EE200100646A (et) Melagatraani peaaegu kristalne vorm
WO2006053625A8 (en) Crystalline form of cefdinir ammonium salt as an intermediate for the preparation of pure cefdinir
EA200601566A1 (ru) Кристаллические формы фармацевтического соединения
IL187441A0 (en) Derivatives of 6,7-dihydro-5h-imidazo[1,2-a] imidazole-3-sulfonic acid